Efficacy and safety of a modified method for blind bedside placement of post-pyloric feeding tube: a prospective preliminary clinical trial

Bing Xiong1, Yinshan Tang1, Ying Jin1, Shen Yingchuan2
1Department of Rehabilitation, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, PR China
2Department of Radiology, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, PR China

Tóm tắt

Objective To compare the efficacy and safety of a new modified method of bedside post-pyloric feeding tube catheterization with the Corpak protocol versus electromagnetic-guided catheterization. Materials and Methods We conducted a single-center, single-blinded, prospective clinical trial. Sixty-three patients were treated with a non-gravity type gastrointestinal feeding tube using different procedures: modified bedside post-pyloric feeding tube placement (M group), the conventional Corpak protocol (C group), and standard electromagnetic-guided tube placement (EM group). Results The success rate in the M group, C group, and EM group was 82.9% (34/41), 70.7% (29/41), and 88.2% (15/17), respectively, with significant differences among the groups. The time required to pass the pylorus was significantly shorter in the M group (26.9 minutes) than in the C group (31.9 minutes) and EM group (42.1 minutes). The proportion of pylorus-passing operations completed within 30 minutes was significantly higher in the M group than in the C group and EM group. No severe complications occurred. Conclusion This modified method of bedside post-pyloric feeding tube catheterization significantly shortened the time required to pass the pylorus with no severe adverse reactions. This method is effective and safe for enteral nutrition catheterization of patients with dysphagia and a high risk of aspiration pneumonia.

Từ khóa


Tài liệu tham khảo

10.1016/j.nut.2015.09.012

10.1016/j.nut.2015.06.007

10.1186/s13054-016-1298-1

10.1186/cc12806

10.1177/0884533613485987

National Health Service. Nasogastric tube misplacement: continuing risk of death and severe harm. Patient Safety Alert. 2016. NHS/PSA/RE/2016/006. Available at: https://improvement.nhs.uk/news-alerts/nasogastric-tube-misplacement-continuing-risk-of-death-severe-harm/. (accessed 7 November 2017).

10.1186/cc120

10.1016/j.ijnurstu.2010.12.004

10.1002/ncp.10189

National Health Service. Placement devices for nasogastric tube insertion do not replace initial position checks. Patient Safety Alert. 2013. NHS/PSA/W/2013/001. Available at: https://www.england.nhs.uk/wp-content/uploads/2013/12/psa-ng-tube.pdf.

10.1177/0115426504019005487

10.1111/j.1365-2648.2007.04401.x

U.S. Food and Drug Administration. 510(k) Premarket notification. Cortrak enteral access device. https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm? ID=K113351. Updated October 16, 2017. (accessed 8 March 2017).

10.1016/j.jocn.2004.04.009

10.1097/CCM.0b013e3181959836

10.1177/088453360101600410

10.1007/s00134-006-0095-8

10.1016/bs.afnr.2016.11.008

10.1177/0148607103027005355

10.1016/j.clnu.2006.01.021

10.1097/CCM.0b013e3181a40116

10.1097/00003246-200112000-00005

10.1097/BCR.0b013e318204b3be

10.1089/neu.2011.1801

10.1016/j.gie.2014.10.040

10.1002/jpen.1015

Xiao J, 2019, Asia Pac J Clin Nutr, 28, 435

10.1016/j.jcrc.2013.06.018

10.1186/s13054-018-1986-0

10.1177/1751143719843425

10.4103/0972-5229.183909

10.1007/s00134-018-5466-4

10.1177/0884533615608363

10.1007/s00134-019-05548-7

10.1097/ANC.0000000000000364

10.1177/000313481708301035

10.1177/0300060519826830

10.1097/00003246-199806000-00023

10.1177/0148607114546166

10.1177/0148607110370976